Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility

By Zander Esther   Chmielarczyk Agnieszka   Heczko Piotr   Seifert Harald   Higgins Paul G.  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 308-311

Oxford University Press

Access to resources Recommend Favorite

Epidemiology of the Acinetobacter -derived cephalosporinase, carbapenem-hydrolysing oxacillinase and metallo-β-lactamase genes, and of common insertion sequences, in epidemic clones of Acinetobacter baumannii from Spain

By Villalón Pilar   Valdezate Sylvia   Medina-Pascual Maria J.   Carrasco Gema   Vindel Ana   Saez-Nieto Juan A.  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 3, 2013-03 ,pp. : 550-553

Oxford University Press

Access to resources Recommend Favorite

Tigecycline: A New Treatment Choice Against Acinetobacter baumannii

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 117-122

Bentham Science Publishers

Access to resources Recommend Favorite

Association of ertapenem and antipseudomonal carbapenem usage and carbapenem resistance in Pseudomonas aeruginosa among 12 hospitals in Queensland, Australia

By McDougall David A. J.   Morton Anthony P.   Playford E. Geoffrey  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 457-460

Oxford University Press

Access to resources Recommend Favorite

bla NDM-1 -carrying Acinetobacter johnsonii detected in hospital sewage

By Zong Zhiyong   Zhang Xingzhuo  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 5, 2013-05 ,pp. : 1007-1010

Oxford University Press

Access to resources Recommend Favorite